Tactile Systems Technology Inc
NASDAQ:TCMD

Watchlist Manager
Tactile Systems Technology Inc Logo
Tactile Systems Technology Inc
NASDAQ:TCMD
Watchlist
Price: 25.07 USD 2.54% Market Closed
Market Cap: $570.3m

Tactile Systems Technology Inc
Net Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Tactile Systems Technology Inc
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Tactile Systems Technology Inc
NASDAQ:TCMD
Net Income
$19.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
30%
Boston Scientific Corp
NYSE:BSX
Net Income
$2.9B
CAGR 3-Years
61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Edwards Lifesciences Corp
NYSE:EW
Net Income
$1.1B
CAGR 3-Years
-11%
CAGR 5-Years
5%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Net Income
$3.2B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Net Income
$6.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
10%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Income
$2.9B
CAGR 3-Years
29%
CAGR 5-Years
22%
CAGR 10-Years
17%
No Stocks Found

Tactile Systems Technology Inc
Glance View

Market Cap
570.3m USD
Industry
Health Care

Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

TCMD Intrinsic Value
20.9 USD
Overvaluation 17%
Intrinsic Value
Price $25.07

See Also

What is Tactile Systems Technology Inc's Net Income?
Net Income
19.1m USD

Based on the financial report for Dec 31, 2025, Tactile Systems Technology Inc's Net Income amounts to 19.1m USD.

What is Tactile Systems Technology Inc's Net Income growth rate?
Net Income CAGR 10Y
30%

Over the last year, the Net Income growth was 13%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett